e-learning
resources
Paris 2018
Sunday, 16.09.2018
Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Obesity hypoventilation syndrome and neurocognitive function - impact of positive airway pressure therapy
S. Sivam (Sydney, Australia), K. Wong (Sydney, Australia), A. Piper (Sydney, Australia), D. Wang (Sydney, Australia), B. Yee (Sydney, Australia), R. Grunstein (Sydney, Australia)
Source:
International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Session:
Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Session type:
Poster Discussion
Number:
421
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Sivam (Sydney, Australia), K. Wong (Sydney, Australia), A. Piper (Sydney, Australia), D. Wang (Sydney, Australia), B. Yee (Sydney, Australia), R. Grunstein (Sydney, Australia). Obesity hypoventilation syndrome and neurocognitive function - impact of positive airway pressure therapy. 421
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Long-term echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Long-term positive airway pressure therapy in obesity hypoventilation syndrome. Cost study
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019
Efficacy of continous positive airway pressure (CPAP) in the treatment of the obesity hypoventilation syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 726s
Year: 2005
Effectiveness of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnoea-hypopnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 682s
Year: 2006
Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Echocardiographic changes with positive airway pressure in obesity hypoventilation syndrome. Pickwick study
Source: International Congress 2017 – CPAP therapy
Year: 2017
Obesity hypoventilation syndrome: efficacy and predictive failure factors for CPAP treatment
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Continuous positive airway pressure or NIV in patients with acute and chronic obesity hypoventilation syndrome?
Source: Sleep and Breathing Conference 2021
Year: 2021
Socieconomic factors affecting the acceptance of continuous positive airway pressure in sleep apnoea syndrome patients
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
Impact of continuous positive airway pressure therapy on atrial electromechanical delay in obesity-hypoventilation syndrome patients
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
Long term positive airway pressure effectiveness in obesity hypoventilation syndrome. Pickwick study results
Source: International Congress 2018 – Hot topics in non-invasive ventilation
Year: 2018
Long term effects of compliance with positive airway pressure (PAP) therapy in patients with obesity hypoventilation syndrome (OHS)
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 320s
Year: 2007
The effect of continuous positive airway pressure on basal metabolism rate in patients with severe obstructive sleep apnea syndrome
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015
Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005
Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013
Compliance of positive airway pressure therapy in patients with sleep related breathing disorder
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Is there a metabolic effect of continuous positive airway pressure in sleep apnoea? Adherence should not be underestimated
Source: Eur Respir J 2009; 34: 1209-1210
Year: 2009
Screening of sleep apnea-induced hypertension and acute effect of continuous positive airway pressure
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept